Abiomed, Inc. (ABMD) Q3 2020 Results Earnings Conference Call February 6, 2020 8:00 AM ET
Company Participants
Michael Minogue - Chairman, President and CEO
Todd Trapp - VP and CFO
Conference Call Participants
Raj Denhoy - Jefferies
Matt O'Brien - Piper Sandler
Danielle Antalffy - SVB Leerink
Chris Pasquale - Guggenheim
Jayson Bedford - Raymond James
Marie Thibault - BTIG
Chris Cooley - Stephens
Margaret Kaczor - William Blair
Operator
Ladies and gentlemen, thank you for standing by. and welcome to the Third Quarter 2020 Abiomed Earnings Conference Call. At this time, all participants lines are in a listen-only mode. After the speakers' presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Mr. Todd Trapp. Sir, you may begin.
Todd Trapp
Thank you, Chrystal. Good morning and welcome to Abiomed's third quarter of fiscal 2020 earnings conference call. This is Todd Trapp, Vice President and Chief Financial officer and I'm here with Mike Minogue, Abiomed's Chairman, President, and Chief Executive Officer.
The format for today's call will be as follows. First, Mike will discuss third quarter business and operational highlights and then I'll review our financial results, which were outlined in today's press release and webcast presentation. These documents can be found on our website under the Investors section. After that, we will open the call to your questions.
Before we begin, I would like to remind everyone that today's call includes forward-looking statements. The company cautions investors that any forward-looking statements involves risks and uncertainties and are not guaranteed of future performance. Actual results may differ materially due to a variety of factors identified in our earnings press release and in our most recent 10-K and 10-Q filed
- Read more current ABMD analysis and news
- View all earnings call transcripts